associ
upper
lower
respiratori
tract
diseas
gastrointestin
ill
adult
pediatr
patient
throughout
world
recent
two
virus
close
relat
human
bocaviru
report
provision
name
human
bocaviru
human
bocaviru
sake
clariti
remaind
articl
refer
origin
human
bocaviru
strain
describ
alland
colleagu
human
bocaviru
remain
unclear
whether
repres
uniqu
viral
entiti
distant
genotyp
singl
viru
recogn
last
sever
month
epidemiolog
clinic
manifest
associ
virus
realiz
incid
human
bocavirus
vari
wide
variou
clinic
present
often
found
associ
potenti
pathogen
phenomenon
led
debat
role
human
bocavirus
true
pathogen
articl
review
publish
studi
discuss
virolog
clinic
diagnost
aspect
newli
recogn
human
virus
first
describ
alland
colleagu
pool
cellfre
supernat
respiratori
sampl
examin
use
random
polymeras
chain
reaction
pcr
techniqu
amplifi
pcr
product
separ
ligat
vector
introduc
escherichia
coli
clone
sequenc
evalu
autom
protocol
compar
known
sequenc
major
clone
determin
human
recogn
bacteri
viral
pathogen
remain
sequenc
parvoviruslik
sequenc
identifi
known
correl
recogn
human
parvovirus
phylogenet
analysi
show
novel
parvoviru
close
relat
bovin
parvoviru
canin
minut
viru
fig
name
human
bocaviru
januari
kapoor
colleagu
report
identif
relat
parvoviru
term
pediatr
stool
sampl
random
pcr
analysi
nucleaseresist
viru
particl
result
amplicon
subclon
plasmid
vector
sequenc
compar
genom
entri
genbank
phylogenet
analysi
show
close
relat
amino
acid
ident
protein
respect
signific
diverg
genom
target
use
detect
explain
remain
unidentifi
point
third
bocaviru
speci
describ
april
australia
provision
name
human
bocaviru
similar
method
use
discoveri
arthur
colleagu
digest
filter
fecal
sampl
nucleas
pellet
virion
evalu
use
degener
oligonucleotid
primedpcr
investig
group
simultan
discov
third
speci
bocaviru
analysi
genom
show
close
homolog
nonstructur
protein
encod
region
similar
structur
protein
encod
region
find
suggest
may
product
recombin
arthur
colleagu
identifi
recombin
site
support
hypothesi
genom
diverg
enough
explain
lack
detect
use
current
publish
primer
set
tabl
clinic
present
season
distribut
preval
yet
character
full
analysi
phylogenet
relationship
requir
determin
correct
taxonomi
viru
famili
human
bocavirus
parvovirus
belong
famili
parvovirida
subfamili
parvovirina
close
relat
bovin
parvoviru
canin
minut
viru
genu
betaparvoviru
see
fig
parvovirus
singlestrand
dna
virus
small
genom
size
kilobas
kb
kb
three
open
read
frame
encod
two
nonstructur
protein
structur
protein
hbov
genom
encod
polymeras
depend
host
cell
dna
polymeras
replic
parvovirus
unenvelop
capsid
icosahedr
symmetri
base
electron
micrograph
appear
structur
similar
member
parvovirida
famili
approxim
nm
diamet
gene
nest
read
frame
use
altern
initi
codon
sequenc
differ
ntermin
extens
region
refer
uniqu
region
play
critic
role
viru
infect
parvovirus
sever
parvovirus
aris
posttransl
proteolyt
cleavag
protein
remain
unclear
exist
human
bocaviru
capsid
parvovirus
consist
copi
viral
capsid
protein
role
protein
human
bocaviru
speci
remain
unknown
zhi
colleagu
creat
infecti
clone
relat
parvoviru
determin
function
gene
find
show
ns
knockout
mutant
abolish
viral
infect
ns
protein
also
seem
vital
genom
transcript
play
role
regul
capsid
gene
express
parvovirus
shown
transmit
variou
rout
includ
respiratori
urin
fecalor
contact
mode
bocaviru
transmiss
hbov
unknown
studi
report
presenc
dna
respiratori
secret
fecal
sampl
dna
also
detect
addit
serum
urin
lymph
node
far
identifi
stool
sampl
similar
respiratori
virus
transmiss
may
occur
sever
rout
includ
inhal
contact
infect
secret
direct
contact
possibl
contamin
surfac
fecalor
standpoint
gastrointestin
ill
although
parvovirus
replic
without
helper
virus
mechan
cell
entri
replic
describ
human
bocaviru
lack
inform
larg
inabl
grow
human
bocavirus
standard
cell
line
follow
alland
initi
descript
human
respiratori
tract
studi
publish
investig
role
viru
respiratori
tract
ill
clinic
find
report
patient
repres
studi
summar
tabl
patient
present
symptom
upper
respiratori
tract
ill
includ
cough
fever
rhinorrhea
pharyng
rash
less
common
addit
patient
tend
report
earach
sever
studi
rais
possibl
associ
sever
respiratori
diseas
report
describ
viru
children
hospit
bronchiol
asthma
exacerb
firsttim
episod
wheez
wheez
describ
numer
studi
one
prospect
studi
compar
respiratori
virus
children
admit
respiratori
infect
wheez
seen
children
recogn
sole
agent
surprisingli
children
coinfect
less
wheez
common
find
includ
tachypnea
fever
hypoxia
one
report
jordan
found
mani
children
hospit
pneumonia
posit
thailand
fri
colleagu
found
patient
like
hospit
pneumonia
odd
ratio
compar
control
report
retrospect
analys
base
hospit
set
studi
patient
requir
stay
intens
care
unit
requir
oxygen
therapi
point
hospit
studi
like
overestim
sever
diseas
associ
select
bia
studi
base
commun
sampl
diseas
mild
rare
requir
admiss
date
report
death
associ
studi
list
underli
comorbid
patient
report
half
patient
underli
medic
condit
common
underli
condit
involv
primari
cardiac
pulmonari
diseas
includ
congenit
heart
lesion
heart
failur
asthma
chronic
obstruct
pulmonari
diseas
prematur
chronic
lung
diseas
report
immunocompromis
patient
respiratori
gastrointestin
ill
schenk
colleagu
report
child
coinfect
rhinoviru
follow
hematopoiet
stem
cell
transplant
patient
develop
fever
dyspnea
wheez
infiltr
chest
radiograph
patient
dna
isol
nasopharyng
stool
blood
sampl
koskenvuo
colleagu
report
seri
children
acut
lymphoblast
leukemia
identifi
present
symptom
febril
upper
respiratori
infect
otiti
media
fever
vomit
diarrhea
isol
fever
garbino
colleagu
report
case
hospit
adult
infect
hiv
patient
eventu
recov
acut
ill
although
studi
systemat
examin
immunocompromis
patient
incid
seem
low
one
studi
muller
colleagu
examin
bronchoalveolar
lavag
specimen
immunocompromis
patient
suspect
pneumocysti
jiroveci
pneumonia
specimen
found
miyaki
colleagu
prospect
examin
bronchoalveolar
lavag
specimen
adult
lung
transplant
recipi
symptomat
nontranspl
patient
fail
find
sampl
studi
argu
pathogen
lower
respiratori
tract
diseas
vulner
popul
mani
report
observ
high
coinfect
rate
difficult
draw
conclus
whether
play
role
pathogen
infect
patient
answer
sever
studi
compar
presenc
asymptomat
control
group
symptomat
individu
one
found
often
symptomat
children
healthi
control
remain
studi
asymptomat
carriag
frequent
asymptomat
infant
acut
respiratori
tract
diseas
recent
report
alland
colleagu
dna
also
present
serum
acut
ill
patient
suggest
dissemin
viru
possibl
find
provid
support
caus
respiratori
ill
vitro
cultur
system
anim
model
avail
better
understand
role
human
respiratori
diseas
establish
gastrointestin
symptom
report
patient
respiratori
infect
see
tabl
suggest
may
limit
respiratori
tract
alon
close
relat
canin
bovin
parvovirus
well
describ
respiratori
enter
pathogen
subsequ
investig
identifi
dna
stool
sampl
patient
gastrointestin
ill
common
gastrointestin
symptom
includ
nausea
vomit
diarrhea
wateri
bloodi
diarrhea
report
conjunct
identifi
stool
sampl
patient
present
gastrointestin
ill
viral
load
stool
significantli
less
viral
load
found
respiratori
tract
specimen
symptomat
patient
similar
studi
respiratori
ill
commonli
codetect
recogn
enter
pathogen
coinfect
rate
rang
identifi
copathogen
includ
noroviru
rotaviru
human
caliciviru
astroviru
adenoviru
campylobact
salmonella
clostridium
difficil
recent
casecontrol
studi
acut
gastroenter
arthur
colleagu
examin
stool
specimen
potenti
pathogen
includ
three
speci
human
bocaviru
dna
human
bocavirus
isol
stool
sampl
make
human
bocavirus
second
common
viral
agent
identifi
rotaviru
clinic
ill
associ
rotaviru
coinfect
seem
significantli
differ
rotaviru
ill
alon
suggest
presenc
worsen
diseas
infrequ
report
stool
origin
immunocompromis
patient
patient
diarrhea
bocaviru
recogn
day
day
follow
stem
cell
transplant
patient
went
develop
dissemin
diseas
one
patient
cell
defici
report
hepat
associ
also
associ
gastroenter
one
patient
b
cell
immunodefici
unlik
respiratori
diseas
larg
investig
gastrointestin
ill
perform
immunocompromis
popul
respiratori
diseas
role
caus
gastrointestin
diseas
unclear
sever
report
identifi
stool
sampl
asymptomat
patient
arthur
colleagu
compar
stool
sampl
posit
symptomat
patient
agematch
asymptomat
control
presenc
fail
achiev
statist
signific
support
hypothesi
may
caus
acut
gastroenter
author
note
lack
symptomat
individu
may
symptom
may
appear
viral
particl
shed
stool
similar
find
made
astroviru
adenoviru
wide
accept
caus
gastroenter
also
significantli
found
often
patient
gastroenter
low
incid
studi
clinic
signific
remain
unclear
data
higher
viral
load
stool
sampl
correspond
activ
diseas
would
support
causal
studi
identifi
coinfect
viral
bacteri
pathogen
substanti
percentag
sampl
although
studi
examin
sampl
pathogen
commonli
report
pathogen
includ
enteroviru
rhinoviru
rsv
parainfluenza
influenza
adenoviru
hmpv
tabl
coinfect
common
occurr
studi
median
rate
coinfect
describ
numer
pathogen
howev
screen
posit
rhinoviru
enterovirus
influenza
highest
incid
coinfect
similarli
sampl
found
posit
high
rate
enteroviru
influenza
rsv
seen
although
like
reflect
high
frequenc
virus
popul
larg
one
may
specul
particular
coinfect
virus
may
provid
biolog
benefit
hbov
recogn
worldwid
associ
upper
lower
respiratori
diseas
sampl
origin
children
predominantli
younger
year
age
within
age
group
children
less
month
age
seem
less
frequent
affect
perhap
passiv
matern
immun
sever
studi
detect
adult
one
studi
screen
children
adult
occur
similar
frequenc
group
studi
report
circul
predominantli
winter
season
season
peak
vari
often
describ
earli
winter
studi
retrospect
use
archiv
respiratori
sampl
submit
analysi
common
respiratori
pathogen
approach
may
lead
misrepresent
viru
circul
sever
report
show
increas
frequenc
infect
spring
choi
colleagu
screen
sampl
period
patient
lower
respiratori
tract
ill
lrti
korea
found
higher
frequenc
may
juli
bastien
colleagu
studi
sampl
origin
patient
canada
report
appar
season
preval
prospect
studi
perform
prospect
investig
children
less
year
age
hospit
respiratori
tract
diseas
detect
everi
month
except
august
studi
peak
month
decemb
isol
occur
novemb
march
sever
seroepidemiolog
studi
perform
assess
preval
infect
childhood
kahn
colleagu
report
antibodi
common
children
screen
serum
sampl
use
viruslik
particlebas
elisa
kahn
colleagu
found
evid
prior
infect
serum
sampl
children
month
age
lowest
preval
antibodi
wherea
children
younger
month
age
older
year
highest
high
proport
seroposit
children
younger
month
age
suggest
vertic
transfer
antibodi
subsequ
declin
percentag
seroposit
children
first
month
life
like
repres
wane
matern
immun
low
percentag
antihbov
antibodi
children
younger
month
age
correl
populationbas
studi
demonstr
children
younger
year
age
higher
occurr
infect
year
age
peopl
circul
antibodi
similar
respiratori
virus
rsv
rhinoviru
hmpv
difficulti
grow
vitro
yet
determin
antibodi
offer
protect
also
unclear
antibodi
confer
protect
vice
versa
protect
antibodi
specul
target
two
viral
capsid
protein
approxim
aa
ident
region
sequenc
divers
occur
n
termin
portion
high
similar
viral
capsid
protein
suggest
crossreact
antibodi
bocaviru
speci
may
occur
studi
seroepidemiolog
perform
thu
far
warrant
bocaviru
speci
recogn
understand
famili
virus
grow
base
avail
sequenc
data
seem
two
close
total
e
relat
genotyp
two
prototyp
strain
ident
nucleotid
protein
level
amino
acid
ident
genotyp
differ
littl
may
assum
repres
one
serotyp
analysi
uniqu
isol
origin
respiratori
sampl
fecal
sampl
demonstr
littl
sequenc
variat
prototyp
strain
also
differ
proport
genotyp
identifi
nasopharyng
fecal
isol
suggest
lineag
infect
respiratori
enter
system
recent
recognit
demonstr
bocaviru
genu
substanti
divers
similar
genom
organ
put
open
read
frame
orf
phylogenet
analysi
orf
show
close
relat
pairwis
distanc
anim
bocavirus
pairwis
distanc
nonstructur
protein
close
relat
wherea
structur
viral
capsid
protein
similar
see
fig
arthur
colleagu
hypothes
may
result
distant
recombin
event
sever
strain
recogn
hand
region
worldwid
howev
true
divers
unclear
follow
discoveri
human
bocaviru
numer
studi
use
convent
pcr
detect
primer
target
gene
predict
amplicon
size
list
tabl
primer
set
use
screen
target
gene
although
wide
variat
detect
studi
site
detect
rate
high
report
one
studi
primer
target
region
slightli
higher
detect
rate
median
see
tabl
differ
surpris
conserv
ns
np
addit
nest
realtim
pcr
use
detect
realtim
pcr
yield
slightli
higher
median
frequenc
detect
variat
detect
studi
like
attribut
multipl
factor
includ
sensit
primer
set
laboratori
techniqu
true
variat
incid
method
use
sampl
collect
ziegler
colleagu
report
use
nucleic
acid
sequenc
base
amplif
nasba
screen
stool
sampl
nasba
isotherm
nucleic
acid
amplif
techniqu
use
altern
pcr
detect
virus
studi
ziegler
cowork
detect
use
nasba
unclear
repres
failur
method
lack
sampl
reaction
inhibitor
stool
sampl
variabl
increas
number
studi
screen
stool
sampl
presenc
base
fecal
respiratori
hbov
sequenc
similar
report
lau
colleagu
genom
target
use
respiratori
sampl
success
stool
sampl
current
literatur
find
found
stool
sampl
less
often
respiratori
sampl
median
versu
unclear
whether
lower
rate
detect
due
truli
lower
incid
stool
decreas
viral
load
presenc
reaction
inhibitor
commonli
found
fece
date
success
propag
standard
cell
line
anim
model
failur
one
major
impedi
understand
viru
parvovirus
larg
host
rang
tissu
tropism
even
among
close
relat
strain
viral
capsid
protein
seem
major
determin
host
specif
relat
human
parvoviru
caus
viremia
replic
bone
marrow
children
adult
liver
fetu
two
studi
identifi
dna
serum
affect
patient
fri
colleagu
demonstr
acut
serum
children
respiratori
diseas
alland
colleagu
detect
dna
half
acutephas
serum
sampl
convalescentphas
serum
specimen
detect
serum
associ
high
viral
load
nasopharynx
even
detect
dna
blood
affect
patient
howev
remain
unclear
viremia
truli
occur
among
healthi
children
viral
respiratori
diseas
often
selflimit
uncompl
diseas
therapi
viral
respiratori
pathogen
shown
effect
treatment
viral
pathogen
influenza
may
shorten
durat
ill
lowrisk
patient
shown
reduc
durat
ill
highrisk
popul
treatment
ribavirin
intraven
immun
globulin
ivig
remain
controversi
set
viral
respiratori
diseas
use
select
popul
sever
rsv
human
parainfluenza
viru
hpiv
diseas
rel
ineffect
antivir
compound
part
host
inflammatori
reaction
lead
substanti
amount
patholog
addit
mani
patient
present
medic
attent
time
past
peak
viral
replic
reason
difficult
demonstr
effect
antivir
compound
sever
case
report
patient
receiv
antivir
treatment
either
prophylaxi
treatment
confirm
presum
viral
infect
schenck
colleagu
report
child
undergon
hematopoiet
stem
cell
transplant
receiv
acyclovir
prophylaxi
howev
subsequ
develop
symptomat
diseas
dna
identifi
respiratori
blood
stool
sampl
patient
complic
hospit
cours
place
ganciclovir
eventu
foscarnet
cytomegaloviru
cmv
viremia
cmv
viral
load
serum
viral
load
becam
undetect
initi
foscarnet
patient
continu
dna
detect
stool
sampl
howev
kupfer
colleagu
report
patient
undergo
treatment
bcell
lymphoma
receiv
ganciclovir
cmv
viremia
also
found
respiratori
secret
clinic
improv
symptom
initi
ganciclovir
support
care
even
intens
care
set
play
larg
role
manag
patient
sever
viral
ill
supplement
oxygen
mechan
ventil
use
support
patient
diseas
one
studi
children
requir
intens
care
although
requir
respiratori
assist
one
patient
coinfect
rsv
requir
support
extracorpor
membran
oxygen
underli
cardiac
physiolog
could
repair
compar
studi
use
antivir
agent
treatment
human
bocavirus
larg
percentag
coinfect
associ
human
bocaviru
infect
suggest
evalu
pathogen
undertaken
patient
diagnos
treatment
copathogen
ie
influenza
may
lead
patient
improv
futur
therapeut
strategi
may
includ
vaccin
hbovneutr
antibodi
small
interf
rna
three
human
bocaviru
speci
recogn
report
associ
respiratori
gastrointestin
diseas
wide
variat
clinic
present
sever
diseas
high
rate
coinfect
role
bocavirus
caus
diseas
debat
one
consider
bocavirus
passeng
virus
littl
clinic
effect
anoth
possibl
bocavirus
requir
presenc
copathogen
infect
sever
studi
suggest
case
howev
bocaviru
identifi
patient
diseas
despit
absenc
copathogen
casecontrol
studi
shown
increas
risk
pneumonia
patient
respiratori
secret
increas
risk
gastroenter
patient
fecal
sampl
two
studi
found
increas
frequenc
symptomat
versu
asymptomat
stool
sampl
one
report
find
worsen
gastrointestin
diseas
coinfect
known
pathogen
rotaviru
question
whether
associ
respiratori
infect
answer
littl
known
recent
describ
bocavirus
clinic
epidemiolog
seroepidemiolog
yet
describ
detail
although
antibodi
common
human
sera
crossreact
investig
furthermor
although
describ
stool
presenc
respiratori
tract
investig
area
research
includ
examin
object
measur
diseas
sever
patient
coinfect
examin
evid
diseas
distant
respiratori
gastrointestin
tract
presenc
describ
serum
lymphat
tissu
conjunct
elev
hepat
enzym
clinic
signific
yet
determin
summari
although
evid
pathogen
human
bocavirus
increas
research
need
determin
sever
hbovassoci
diseas
clinic
outcom
